[Morphological imaging for response assessment in metastatic bone disease]

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Context:

• Metastatic bone disease presents challenges for treatment response assessment.
• Conventional radiography (X-ray) has limited utility, primarily for long bones.
• Computed Tomography (CT) excels at evaluating osteolysis and osteosclerosis.

Purpose:

• To evaluate the role of morphological Magnetic Resonance Imaging (MRI) in assessing treatment response in metastatic bone disease.
• To compare the efficacy of different imaging modalities for bone lesion evaluation.

Summary:

• Magnetic Resonance Imaging (MRI) is the gold standard for bone marrow imaging.
• Morphological MRI, especially using T1-weighted sequences, provides confident assessment of lesion behavior under therapy.
• Radiotherapy and interventional procedures can cause changes in bone cortex and marrow, which must be considered.

Impact:

• Improved accuracy in monitoring therapeutic effectiveness for bone metastases.
• Enhanced clinical decision-making through reliable imaging-based response evaluation.
• Potential for optimized patient management and treatment strategies in oncology.